Roche underscores its long-term commitment to Taiwan’s Healthy Taiwan vision through sustained R&D investment, clinical trials, and real-world data supporting precision medicine. By advancing patient access and advocating for value-based healthcare, Roche aims to help Taiwan build a more innovation-friendly and sustainable biomedical ecosystem.

Taiwan’s Healthy Taiwan Initiative, championed by President Lai Ching-te, marks a bold shift toward prevention, digital innovation, and holistic care—aiming to add healthy years to life and tackle chronic diseases, mental health, and cancer head-on. With expert-driven reforms and a public-private push, the initiative is laying the groundwork for a stronger, more resilient healthcare system.